Bullish on COCH citing a $30M raise, Nasdaq listing requirement, CEO option incentive, and expected FDA approval in 2027.
COCH — LONG The author argues COCH raised $30M via an S-1A filing and will meet the February 23 requirement, with the CEO incentivized to push the stock to $1 by May via 200k options at $0.53. They expect FDA approval in 2027 to make the company worth at least $500M, implying a fair price of $15. The author claims the stock is being heavily manipulated like prior names RANI, SCNX, and VTYX, and should be at least $4 now. Main risk is the heavy manipulation and the binary FDA approval timeline.
FDaA approval in 2027 gonna send this to being worth 500m at least imo so 15 bucks would be fair price. obviously being manipulated heavy rn like $RANI before flying, $SCNX, $VTYX. Gonna be a run up till approval too and this should be 4 bucks rn minimum.
This Reddit post, published February 12, 2026, features u/Spirited_Profile4499 discussing COCH. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/Spirited_Profile4499 · Tickers: COCH